Endothelial cyclooxygenase-1 paradoxically drives local vasoconstriction and atherogenesis despite underpinning prostacyclin generation
Open Access
- 19 March 2021
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 7 (12) , eabf6054
Abstract
A paradoxical role for vascular COX-1 products in vasoconstriction and atherogenesis highlights it as a novel therapeutic target.Keywords
Funding Information
- National Institutes of Health (R01-CA084572 R01-CA123055 P50-CA086306)
- British Heart Foundation (FS/16/1/31699 RG/18/4/33541)
- British Heart Foundation (RG/18/4/33541)
- Phelps Family Foundation
- Crump Family Foundation
This publication has 69 references indexed in Scilit:
- LC-MS/MS Confirms That COX-1 Drives Vascular Prostacyclin Whilst Gene Expression Pattern Reveals Non-Vascular Sites of COX-2 ExpressionPLOS ONE, 2013
- Cyclooxygenase-1, not cyclooxygenase-2, is responsible for physiological production of prostacyclin in the cardiovascular systemProceedings of the National Academy of Sciences, 2012
- Involvement of cyclo‐oxygenase‐1‐mediated prostacyclin synthesis in the vasoconstrictor activity evoked by ACh in mouse arteriesExperimental Physiology, 2011
- Thrombosis Is Reduced by Inhibition of COX-1, but Unaffected by Inhibition of COX-2, in an Acute Model of Platelet Activation in the MousePLOS ONE, 2011
- Endothelium‐mediated control of vascular tone: COX‐1 and COX‐2 productsBritish Journal of Pharmacology, 2011
- Nitric Oxide and Prostaglandin Inhibition During Acetylcholine‐Mediated Cutaneous Vasodilation in HumansMicrocirculation, 2008
- Vascular wall–produced prostaglandin E2 exacerbates arterial thrombosis and atherothrombosis through platelet EP3 receptorsJournal of Experimental Medicine, 2007
- Prostacyclin protects against elevated blood pressure and cardiac fibrosisCell Metabolism, 2005
- Cardiovascular Events Associated with Rofecoxib in a Colorectal Adenoma Chemoprevention TrialNew England Journal of Medicine, 2005
- CONGENITAL DEFICIENCY OF THROMBOXANE AND PROSTACYCLINThe Lancet, 1980